Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer’s disease patients and controls
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer’s disease patients and controls
Authors
Keywords
Apolipoprotein E, Cerebrospinal fluid, Isoform, Mass spectrometry, Plasma
Journal
ACTA NEUROPATHOLOGICA
Volume 127, Issue 5, Pages 633-643
Publisher
Springer Nature
Online
2014-03-18
DOI
10.1007/s00401-014-1266-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microgliain vitro
- (2014) Sandra D. Mulder et al. GLIA
- Assessment of Peptide Chemical Modifications on the Development of an Accurate and Precise Multiplex Selected Reaction Monitoring Assay for Apolipoprotein E Isoforms
- (2014) Eduardo Martínez-Morillo et al. JOURNAL OF PROTEOME RESEARCH
- Brain regional correlation of amyloid-β with synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-β accumulation
- (2013) Mitsuru Shinohara et al. ACTA NEUROPATHOLOGICA
- Cerebrospinal Fluid Apolipoprotein E Concentration and Severity of Cognitive Impairment in Patients With Newly Diagnosed Alzheimer’s Disease
- (2013) Christian Schmidt et al. American Journal of Alzheimers Disease and Other Dementias
- Binding of Apolipoprotein E Inhibits the Oligomer Growth of Amyloid-β Peptide in Solution as Determined by Fluorescence Cross-correlation Spectroscopy
- (2013) Sonny Ly et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice
- (2013) Katherine D LaClair et al. Molecular Neurodegeneration
- Fluid biomarkers in Alzheimer’s disease – current concepts
- (2013) Christoffer Rosén et al. Molecular Neurodegeneration
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
- (2013) Chia-Chen Liu et al. Nature Reviews Neurology
- Low CSF Levels of Both α-Synuclein and the α-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy
- (2013) Malin Wennström et al. PLoS One
- ApoE influences amyloid- (A ) clearance despite minimal apoE/A association in physiological conditions
- (2013) P. B. Verghese et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gene Transfer of Human Apoe Isoforms Results in Differential Modulation of Amyloid Deposition and Neurotoxicity in Mouse Brain
- (2013) E. Hudry et al. Science Translational Medicine
- Cerebrovascular Effects of Apolipoprotein E
- (2013) Berislav V. Zlokovic JAMA Neurology
- Apolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from mice
- (2012) Min Liu et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease
- (2012) Carlos Cruchaga et al. HUMAN MOLECULAR GENETICS
- Total ApoE and ApoE4 Isoform Assays in an Alzheimer's Disease Case-control Study by Targeted Mass Spectrometry (n= 669): A Pilot Assay for Methionine-containing Proteotypic Peptides
- (2012) Romain Simon et al. MOLECULAR & CELLULAR PROTEOMICS
- In Vivo Human Apolipoprotein E Isoform Fractional Turnover Rates in the CNS
- (2012) Kristin R. Wildsmith et al. PLoS One
- Plasma Apolipoprotein Levels Are Associated with Cognitive Status and Decline in a Community Cohort of Older Individuals
- (2012) Fei Song et al. PLoS One
- ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models
- (2012) P. E. Cramer et al. SCIENCE
- APOE ϵ4 Increases Risk for Dementia in Pure Synucleinopathies
- (2012) Debby Tsuang et al. JAMA Neurology
- Apolipoprotein E in Alzheimer's disease and other neurological disorders
- (2011) Philip B Verghese et al. LANCET NEUROLOGY
- Prevalence of Apolipoprotein E4 Genotype and Homozygotes (APOE e4/4) among Patients Diagnosed with Alzheimer’s Disease: A Systematic Review and Meta-Analysis
- (2011) Alex Ward et al. NEUROEPIDEMIOLOGY
- Plasma apolipoprotein E and Alzheimer disease risk: The AIBL study of aging
- (2011) V. B. Gupta et al. NEUROLOGY
- Human apoE Isoforms Differentially Regulate Brain Amyloid- Peptide Clearance
- (2011) J. M. Castellano et al. Science Translational Medicine
- Formation and function of apolipoprotein E-containing lipoproteins in the nervous system
- (2010) Jean E. Vance et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age
- (2009) Eloise Kok et al. ANNALS OF NEUROLOGY
- Plasma lipoproteins: genetic influences and clinical implications
- (2009) Robert A. Hegele NATURE REVIEWS GENETICS
- Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
- (2008) D. R. Riddell et al. JOURNAL OF NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started